APA (7th ed.) Citation

MS, M., AM, B., JW, D., DJ, F., A, Q., HP, C., . . . JM, R. (2021). Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy. ACS pharmacology & translational science, 4(4), 1306. https://doi.org/10.1021/acsptsci.0c00162

Chicago Style (17th ed.) Citation

MS, Moehle, et al. "Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy." ACS Pharmacology & Translational Science 4, no. 4 (2021): 1306. https://doi.org/10.1021/acsptsci.0c00162.

MLA (9th ed.) Citation

MS, Moehle, et al. "Discovery of the First Selective M4 Muscarinic Acetylcholine Receptor Antagonists with in Vivo Antiparkinsonian and Antidystonic Efficacy." ACS Pharmacology & Translational Science, vol. 4, no. 4, 2021, p. 1306, https://doi.org/10.1021/acsptsci.0c00162.